1
00:00:02,360 --> 00:00:05,760
Speaker 1: Global business news twenty four hours a day at Bloomberg

2
00:00:05,800 --> 00:00:08,880
Speaker 1: dot Com, the Radio plus mobile. Last head on your radio.

3
00:00:09,160 --> 00:00:13,400
Speaker 1: This is a Bloomberg Business Flash call Bloomberg World Headquarters.

4
00:00:13,440 --> 00:00:16,079
Speaker 1: I'm Charlie Holt Stocks Laurel. Let's head right over to

5
00:00:16,120 --> 00:00:19,120
Speaker 1: the first Word breaking news desk for today's afternoon call.

6
00:00:19,239 --> 00:00:22,799
Speaker 1: Here he is Bill Maloney. Good afternoon, Charlie. US stocks

7
00:00:22,840 --> 00:00:25,360
Speaker 1: are under pressure today, with the DAL currently down a

8
00:00:25,440 --> 00:00:28,280
Speaker 1: hundred and ten points, SUPs drop ten and as that

9
00:00:28,480 --> 00:00:31,760
Speaker 1: falls eleven, the small cap six hundreds down three points.

10
00:00:31,800 --> 00:00:34,960
Speaker 1: In the US ten yield at one point five seven percent.

11
00:00:35,440 --> 00:00:38,120
Speaker 1: Nine out of tennesseev sectors are lower, led by losses

12
00:00:38,120 --> 00:00:42,959
Speaker 1: and energy industrials and telecom Fractional games for consumer discretionary

13
00:00:43,400 --> 00:00:48,840
Speaker 1: down transports fall seventy seven, nazerbotechs outperformed Game fourteen, utilities

14
00:00:48,920 --> 00:00:51,760
Speaker 1: drop three, and the vix is higher by eleven percent.

15
00:00:52,240 --> 00:00:54,960
Speaker 1: Down Leaders of the downside included Chevron, x On Mobile,

16
00:00:55,040 --> 00:00:59,000
Speaker 1: and Apple, while Nike, Walmart, and DuPont led to the upside.

17
00:00:59,440 --> 00:01:01,840
Speaker 1: Ro protect Alogy stall as much as eight point one

18
00:01:01,880 --> 00:01:05,280
Speaker 1: percent after its earnings. Well shares of Buffalo Wild Wings

19
00:01:05,280 --> 00:01:08,720
Speaker 1: seerves as much as seven percentage today after an activist

20
00:01:08,720 --> 00:01:12,000
Speaker 1: investor acquired a five point one percent steak. Find me

21
00:01:12,040 --> 00:01:14,800
Speaker 1: someone names such report after the belts to night include Gilead,

22
00:01:14,880 --> 00:01:19,160
Speaker 1: Las Vegas, Sands, Express Scripts, and Texas Instruments. Live on

23
00:01:19,240 --> 00:01:21,600
Speaker 1: the first and breaking newsdask on Bill Maloney, cho all right,

24
00:01:21,600 --> 00:01:23,839
Speaker 1: thank you very much, Bill Maloney. To hear live breaking

25
00:01:23,840 --> 00:01:27,040
Speaker 1: news over your Bloomberg time squaw caaskuu a w K

26
00:01:27,360 --> 00:01:30,919
Speaker 1: on your terminal. I'm Charlie pellout. Dan's a Bloomberg business

27
00:01:30,959 --> 00:01:36,760
Speaker 1: flash now on Bluebird Radio. We take stock of healthcare.

28
00:01:38,080 --> 00:01:40,800
Speaker 1: We call it k B for sure. It's a major

29
00:01:40,920 --> 00:01:44,560
Speaker 1: source of healthcare expenditures. The issue of drug pricing has

30
00:01:44,640 --> 00:01:46,840
Speaker 1: been at the forefront, certainly in the political ground for

31
00:01:46,840 --> 00:01:49,080
Speaker 1: the last few months. I think we're living in a

32
00:01:49,200 --> 00:01:53,320
Speaker 1: very special time in the history of the pharmaceutical industry.

33
00:01:53,480 --> 00:01:57,120
Speaker 1: Before we start any pharmaceutical discovery, we want to understand

34
00:01:57,120 --> 00:02:00,280
Speaker 1: the patient biology for three percent of all pilot next

35
00:02:00,280 --> 00:02:02,680
Speaker 1: to start actually get a drug of food. It's a

36
00:02:02,800 --> 00:02:06,080
Speaker 1: very hard thing to do. Bloomberg takings to healthcare and

37
00:02:06,160 --> 00:02:10,680
Speaker 1: focus on Bloomberg radios, the price the cost of healthcare

38
00:02:10,880 --> 00:02:15,640
Speaker 1: in focus. Joining us now Susan Devour, President chief executive

39
00:02:15,760 --> 00:02:20,720
Speaker 1: of Premiere. Premiere, of course one of the leading provider

40
00:02:20,800 --> 00:02:25,239
Speaker 1: driven healthcare performance improvement companies. Susan joins us now. Susan,

41
00:02:25,280 --> 00:02:28,280
Speaker 1: thanks very much for being with us. Thank you tell

42
00:02:28,360 --> 00:02:31,160
Speaker 1: us a little bit about a Premiere and the quest too,

43
00:02:31,200 --> 00:02:35,080
Speaker 1: as you describe it in many of your your articles,

44
00:02:35,120 --> 00:02:39,440
Speaker 1: the prescription to fixed healthcare. How does Premiere fit in? So,

45
00:02:39,600 --> 00:02:43,839
Speaker 1: Premiere is an alliance of healthcare systems. We work with

46
00:02:44,040 --> 00:02:47,680
Speaker 1: secent of the hospitals and health healthcare systems around the

47
00:02:47,720 --> 00:02:52,920
Speaker 1: country trying to drive quality improvement, cost reduction, safety improvement,

48
00:02:52,919 --> 00:02:56,320
Speaker 1: and really help healthcare systems transform the way they're taking

49
00:02:56,320 --> 00:02:58,720
Speaker 1: care of the millions of patients in this country. And

50
00:02:58,720 --> 00:03:02,080
Speaker 1: of course a big part of that is UH drug prices.

51
00:03:02,160 --> 00:03:05,680
Speaker 1: Drug costs represent about four percent of the United States

52
00:03:05,680 --> 00:03:09,280
Speaker 1: three trillion dollar annual health expenditure. They're growing rapidly, total

53
00:03:09,360 --> 00:03:12,240
Speaker 1: drug spending up twelve point two percent last year. As

54
00:03:12,280 --> 00:03:15,680
Speaker 1: you point out in a recent analysis, you are have

55
00:03:15,919 --> 00:03:20,200
Speaker 1: a lot of insight and suggestions here. I'm particularly interested

56
00:03:20,600 --> 00:03:24,560
Speaker 1: in how generic drug price increases are contributing to the

57
00:03:24,600 --> 00:03:29,080
Speaker 1: growth in drug spending. So thank you for the question,

58
00:03:29,160 --> 00:03:32,800
Speaker 1: and at Premiere we're focused every day on on the

59
00:03:32,880 --> 00:03:35,520
Speaker 1: cost of not only drugs, but medical devices and the

60
00:03:35,600 --> 00:03:38,600
Speaker 1: overall cost of care. And when you look at drugs spending,

61
00:03:39,080 --> 00:03:41,880
Speaker 1: as you said, UM, it's at at one of the

62
00:03:41,960 --> 00:03:45,840
Speaker 1: highest levels it's been at in decades. And we really

63
00:03:45,880 --> 00:03:50,480
Speaker 1: think it Premiere the opportunity to bring competitive friction UH

64
00:03:50,520 --> 00:03:55,760
Speaker 1: to the drug marketplace. UM. Pushing along faster FDA approval,

65
00:03:56,360 --> 00:04:00,840
Speaker 1: getting faster adoption, of continuing adoption of in erics, and

66
00:04:01,040 --> 00:04:07,080
Speaker 1: also of biosimilar drugs, bringing transparency to the industry, all

67
00:04:07,120 --> 00:04:10,160
Speaker 1: of those things we think will be helpful in bringing

68
00:04:10,240 --> 00:04:13,120
Speaker 1: drug prices down over time. Do you think that the

69
00:04:13,120 --> 00:04:17,760
Speaker 1: federal government should be able to negotiate drug prices? You know,

70
00:04:17,839 --> 00:04:21,440
Speaker 1: at Premiere, we don't think price controls work. We think

71
00:04:21,440 --> 00:04:24,640
Speaker 1: it's very hard for government to make those clinical decisions

72
00:04:24,720 --> 00:04:28,279
Speaker 1: or intervene in those clinical decisions. We also don't think

73
00:04:28,320 --> 00:04:31,560
Speaker 1: that they can work rapidly enough to keep up with

74
00:04:31,600 --> 00:04:34,000
Speaker 1: what it takes to bring new drugs to market and

75
00:04:34,120 --> 00:04:37,479
Speaker 1: to evaluate the clinical effectiveness of them. So we don't

76
00:04:37,520 --> 00:04:40,280
Speaker 1: think price controls work, and a Premiere, we don't think

77
00:04:40,600 --> 00:04:44,600
Speaker 1: reimportation works. What we think works is bringing competitive friction

78
00:04:45,080 --> 00:04:50,360
Speaker 1: speeding up the approval process, educating consumers and educating providers

79
00:04:50,360 --> 00:04:54,039
Speaker 1: on the effectiveness of these generics and biosimilars, and we

80
00:04:54,080 --> 00:04:58,360
Speaker 1: think those things work. You know, you've also been appounding

81
00:04:58,400 --> 00:05:03,360
Speaker 1: the table about how the Affordable Care Act has affected hospitals,

82
00:05:03,360 --> 00:05:06,480
Speaker 1: and you want to reset the button on pay for

83
00:05:06,839 --> 00:05:10,440
Speaker 1: quality programs, how they're implemented for hospitals, What are they

84
00:05:10,520 --> 00:05:14,520
Speaker 1: and why are they contributing to costs? So, actually, at Premiere,

85
00:05:14,560 --> 00:05:17,400
Speaker 1: we think that there's a lot of bipartisans support, and

86
00:05:17,400 --> 00:05:21,400
Speaker 1: in an election year that's important for these forward looking

87
00:05:21,520 --> 00:05:25,640
Speaker 1: forms of paying for health care. So the idea that

88
00:05:25,680 --> 00:05:30,880
Speaker 1: you as a consumer would have UM your providers have accountability,

89
00:05:30,920 --> 00:05:34,680
Speaker 1: your doctors, your hospitals, your nursing homes, have connected and

90
00:05:34,720 --> 00:05:41,120
Speaker 1: coordinated accountability for the overall clinical efficacy and cost of

91
00:05:41,200 --> 00:05:45,160
Speaker 1: your care, we think has broad bipartisan support. And so

92
00:05:45,279 --> 00:05:48,800
Speaker 1: all these new models that are being rolled out by

93
00:05:48,920 --> 00:05:53,000
Speaker 1: the centers for Medicare and Medicaid, whether it's bundling payments together,

94
00:05:53,200 --> 00:05:56,920
Speaker 1: whether it's something called an accountable care organization, these are

95
00:05:56,960 --> 00:06:02,200
Speaker 1: all designed to try to bring coordination and interoperability of

96
00:06:02,240 --> 00:06:09,040
Speaker 1: technology systems and actually um patient involvement in the overall

97
00:06:09,120 --> 00:06:13,000
Speaker 1: coordination of care delivery. I want if you could talk

98
00:06:13,040 --> 00:06:16,800
Speaker 1: a little bit about prescription drugs, because prescription drugs are

99
00:06:16,839 --> 00:06:19,920
Speaker 1: the most expensive in the United States there twice as

100
00:06:19,960 --> 00:06:23,719
Speaker 1: high as prescription drug prices in the United Kingdom, Australia

101
00:06:23,839 --> 00:06:27,760
Speaker 1: or Canada. Well, I do think and at Premiere we

102
00:06:27,920 --> 00:06:32,479
Speaker 1: see because we do um GPO contracts and we try

103
00:06:32,520 --> 00:06:37,520
Speaker 1: to bring competitive friction to the contracting with pharmaceutical companies.

104
00:06:37,560 --> 00:06:41,560
Speaker 1: But we do see um that the United States funds

105
00:06:41,600 --> 00:06:44,520
Speaker 1: a lot of the innovation and a lot of the

106
00:06:44,560 --> 00:06:47,880
Speaker 1: cost of research and development to bring drugs to market

107
00:06:48,680 --> 00:06:51,960
Speaker 1: UM and we do see that with competition and with

108
00:06:52,120 --> 00:06:56,720
Speaker 1: the use of generics and biosimilars, you can see very

109
00:06:56,760 --> 00:06:59,240
Speaker 1: significant reductions in the price. So if we can get

110
00:06:59,279 --> 00:07:02,720
Speaker 1: generics to the market faster, very often they have an

111
00:07:02,720 --> 00:07:05,440
Speaker 1: eight or nine reduction in the price of the drug.

112
00:07:05,520 --> 00:07:09,120
Speaker 1: If we can get these biosimilars to market like they've

113
00:07:09,160 --> 00:07:12,400
Speaker 1: gotten them to market in Europe, uh, you'll see a

114
00:07:12,480 --> 00:07:16,640
Speaker 1: thirty reduction in the price of those drugs. So again

115
00:07:16,760 --> 00:07:21,080
Speaker 1: we think it's having clinical data on how these equivalent

116
00:07:21,120 --> 00:07:24,040
Speaker 1: drugs work. Speeding up the f d A. R f

117
00:07:24,160 --> 00:07:28,400
Speaker 1: d A is a very long process and cycle time,

118
00:07:28,480 --> 00:07:30,120
Speaker 1: so so we think there are a lot of things

119
00:07:30,120 --> 00:07:33,320
Speaker 1: that can be done to improve this Sits DeVore, President

120
00:07:33,440 --> 00:07:37,200
Speaker 1: CEO of Premiere on the front lines of dealing with

121
00:07:37,520 --> 00:07:41,280
Speaker 1: the health care system, and Kathie Hayes along with PM Fox,

122
00:07:41,560 --> 00:07:47,320
Speaker 1: This is Bloomberg. Bloomberg taking Stock is brought to by

123
00:07:47,320 --> 00:07:50,200
Speaker 1: Time winner Cable Business Class. If your business relies on

124
00:07:50,240 --> 00:07:52,960
Speaker 1: the phone company, you may be getting less than you deserve.

125
00:07:53,120 --> 00:07:55,840
Speaker 1: Make the switch to more speed, more value, more savings.

126
00:07:56,160 --> 00:07:59,240
Speaker 1: Visit Business dot t WC dot com, slash more